Control Bionics Limited (CBL.AX)
AUD 0.06
(-1.69%)
AUD 0.06
(-1.69%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 5.12 Million | 5.43 Million | 4.38 Million | 3.92 Million | 3.09 Million | 781.44 Thousand |
| Cost of Revenue | 1.45 Million | 1.93 Million | 1.97 Million | 1.42 Million | 2.88 Million | 1.41 Million |
| Gross Profit | 3.67 Million | 3.5 Million | 2.4 Million | 2.49 Million | 215.51 Thousand | -634.06 Thousand |
| Operating Expenses | 9.82 Million | 9.79 Million | 9 Million | 6.58 Million | 1.41 Million | 1.41 Million |
| Selling, General and Administrative Expenses | 8.11 Million | 5.9 Million | 5.62 Million | 3.76 Million | 1.35 Million | 1.05 Million |
| Research and Development Expenses | 1.71 Million | 230.98 Thousand | 328.88 Thousand | 166.23 Thousand | 68.3 Thousand | 361.22 Thousand |
| Other Expenses | - | 656.01 Thousand | 3.05 Million | 2.64 Million | - | - |
| Cost and Expenses | 11.28 Million | 11.72 Million | 10.98 Million | 8.01 Million | 4.3 Million | 2.83 Million |
| Operating Income | -5.92 Million | -5.61 Million | -6.09 Million | -3.51 Million | -1.2 Million | -2.05 Million |
| Interest Expense | 56.28 Thousand | 12.31 Thousand | 8887.00 | 32.77 Thousand | 3330.00 | 436.00 |
| Income Tax Expense | - | 668.32 Thousand | 8887.00 | 636.85 Thousand | -102.97 Thousand | -114.86 Thousand |
| Earnings before Tax | -5.91 Million | -5.63 Million | -6.1 Million | -3.55 Million | -1.1 Million | -2.04 Million |
| Net Income | -5.91 Million | -5.63 Million | -6.11 Million | -4.18 Million | -1 Million | -1.93 Million |
| Earnings Per Share Basic | -0.04 | -0.06 | -0.06 | -0.05 | -0.01 | -0.02 |
| Earnings Per Share Diluted | -0.04 | -0.06 | -0.06 | -0.05 | -0.01 | -0.02 |
| Weighted Average Shares Outstanding | 159.39 Million | 100.05 Million | 94.56 Million | 92.59 Million | 92.39 Million | 92.39 Million |
| Weighted Average Shares Outstanding (Diluted) | 159.39 Million | 100.05 Million | 94.56 Million | 92.59 Million | 92.39 Million | 92.39 Million |
| Gross Margin | 0.72 | 0.64 | 0.55 | 0.64 | 0.07 | -0.81 |
| EBIT Margin | -1.01 | -0.95 | -1.27 | -0.84 | -0.35 | -2.61 |
| Profit Margin | -1.15 | -1.04 | -1.39 | -1.07 | -0.32 | -2.47 |
| EBITDA | -5.15 Million | -5.13 Million | -5.58 Million | -3.39 Million | -989.95 Thousand | -1.92 Million |
| Earnings Before Tax Margin | -1.16 | -1.03 | -1.39 | -0.90 | -0.39 | -2.62 |
| Breakdown | 2024 FY | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 |
|---|---|---|---|---|---|---|
| Revenue | 5.35 Million | 1.19 Million | 1.19 Million | 2.96 Million | 1.58 Million | 2.74 Million |
| Cost of Revenue | 7.74 Million | 329.67 Thousand | 329.67 Thousand | 3.78 Million | 426.18 Thousand | 3.44 Million |
| Gross Profit | -2.39 Million | 863.59 Thousand | 863.59 Thousand | -822.47 Thousand | 1.16 Million | -698.72 Thousand |
| Operating Expenses | 4.47 Million | 2.65 Million | 2.65 Million | 1.88 Million | 2.33 Million | 2.31 Million |
| Selling, General and Administrative Expenses | - | 1.87 Million | 1.87 Million | 1.71 Million | 2.33 Million | 2.16 Million |
| Research and Development Expenses | - | 772.05 Thousand | 772.05 Thousand | 170.75 Thousand | 91.56 Thousand | 149.88 Thousand |
| Other Expenses | - | - | - | - | - | - |
| Cost and Expenses | 12.21 Million | 2.98 Million | 2.98 Million | 5.66 Million | 2.75 Million | 5.75 Million |
| Operating Income | -6.86 Million | -1.78 Million | -1.78 Million | -2.7 Million | -1.12 Million | -3 Million |
| Interest Expense | 56.28 Thousand | 41 Thousand | - | 15.27 Thousand | - | - |
| Income Tax Expense | -850.39 Thousand | -367.09 Thousand | -105.91 Thousand | -483.3 Thousand | - | 4.00 |
| Earnings before Tax | -6.76 Million | -1.86 Million | -1.86 Million | -2.67 Million | -1.17 Million | -2.62 Million |
| Net Income | -5.91 Million | -1.86 Million | -1.86 Million | -2.19 Million | -1.17 Million | -2.62 Million |
| Earnings Per Share Basic | - | -0.01 | -0.01 | -0.02 | -0.01 | -0.03 |
| Earnings Per Share Diluted | - | -0.01 | -0.01 | -0.02 | -0.01 | -0.03 |
| Weighted Average Shares Outstanding | 159.39 Million | 212.48 Million | 212.48 Million | 106.32 Million | 106.32 Million | 100.32 Million |
| Weighted Average Shares Outstanding (Diluted) | 159.39 Million | 212.46 Million | 212.46 Million | 106.32 Million | 106.32 Million | 100.32 Million |
| Gross Margin | -0.45 | 0.72 | 0.72 | -0.28 | 0.73 | -0.25 |
| EBIT Margin | - | -1.37 | -1.37 | -0.83 | -0.64 | -1.00 |
| Profit Margin | -1.11 | -1.56 | -1.56 | -0.74 | -0.74 | -0.96 |
| EBITDA | - | -1.63 Million | -1.63 Million | -2.44 Million | -1.01 Million | -2.75 Million |
| Earnings Before Tax Margin | -1.28 | -1.50 | -1.50 | -0.91 | -0.71 | -1.10 |
002077
STM
KPEA
688789
MKS
DIA